Systemic Juvenile Idiopathic Arthritis

• FDA label_change · 2025-12-10
  FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for Actemra (tocilizumab) submitted by Genentech, Inc., related to changes to the product labeling.